NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 39,000 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
39,000 Papers indexed
1,440 Papers AI scored
39,000 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-10-07 09:15 AM
1 Direct-Acting Antiviral Therapy in Patients With Hepatocellular Carcinoma Receiving Non-Curative Treatment: High Sustained Virological Response Rates and Preservation of Liver Functional Reserve. Journal of viral hepatitis 47.60 Oct 07, 2026 2 Eosinophilic angiocentric fibrosis in paediatric IgG4-related disease. BMJ case reports — Oct 07, 2026 3 Efficacy and safety of MEK inhibitors for NF1-associated symptomatic, inoperable plexiform neurofibromas: A systematic review and meta-analysis. PloS one 76.50 Oct 07, 2026 4 Systematic review of the impact of germline mutations from unrelated bone marrow donors on post-allogeneic transplantation. Expert review of molecular diagnostics 51.00 Oct 07, 2026 5 Pediatric and Adult Sinonasal Phosphaturic Mesenchymal Tumors: CDKN2A Copy Number Alterations and Their Association with Recurrence. Head and neck pathology — Oct 07, 2026 6 Spinal ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes with a focus on the pediatric population (Part III of ependymomas across compartments). Journal of neuro-oncology 54.60 Oct 07, 2026 7 Paediatric biobanking in the era of precision medicine: ethical, regulatory, and scientific challenges from childhood to adulthood. European journal of pediatrics 39.90 Oct 07, 2026 8 Abatacept in biologic-refractory juvenile idiopathic arthritis-associated uveitis: a case-based review. Clinical rheumatology 46.80 Oct 07, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

39000 results
C
Atypical presentations and neurosurgical Synergy in the treatment of paravertebral tumors in children: Lessons from a single institution.
PMID 40517080 Published: 2025-05-30 Ingested: 2026-08-02 12:12 AM Pediatrics and neonatology
AI -
Standard 62.64
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 48.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Stroke-like migraine attack after radiation therapy (SMART) syndrome in a pediatric patient with a ventriculoperitoneal shunt: illustrative case.
PMID 40418892 Published: 2025-05-26 Ingested: 2026-08-02 12:04 AM Journal of neurosurgery. Case lessons
AI -
Standard 62.64
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 48.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Evidence of supratentorial white matter injury prior to treatment in children with posterior fossa tumors using diffusion MRI.
PMID 40376680 Published: 2025-03-05 Ingested: 2026-08-02 12:03 AM Neuro-oncology advances
AI -
Standard 62.64
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 48.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Endocrine manifestations of pediatric CNS tumors at diagnosis and as sequalae of treatment.
PMID 40216493 Published: 2025-03-08 Ingested: 2026-08-02 12:04 AM Seminars in pediatric neurology
AI -
Standard 62.64
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 48.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Comparison study between different treatment planning techniques for medulloblastoma in terms of dosimetry, radiobiology, and secondary cancer risk.
PMID 40214370 Published: 2025-04-02 Ingested: 2026-08-02 12:03 AM Journal of cancer research and therapeutics
AI -
Standard 62.64
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 48.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Empowering pediatric, adolescent, and young adult patients with cancer utilizing generative AI chatbots to reduce psychological burden and enhance treatment engagement: a pilot study.
PMID 40070545 Published: 2025-02-25 Ingested: 2026-08-02 12:03 AM Frontiers in digital health
AI -
Standard 62.64
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 48.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Infections Due to Corynebacterium kroppenstedtii With Focus on Granulomatous Lobular Mastitis for Tissue Specificity, Pathogenesis, Bacteriologic Workup, and Treatment.
PMID 39800878 Published: 2025-09-01 Ingested: 2026-08-02 12:05 AM Archives of pathology & laboratory medicine
AI -
Standard 62.64
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 43.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection/acquired immunodeficiency syndrome (2024 edition).
PMID 39602327 Published: 2024-11-18 Ingested: 2026-08-02 12:02 AM Chinese medical journal
AI -
Standard 62.64
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 62.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 48.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Previous
Page 1424 of 3250
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic